Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program
December 19, 2024 09:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Veterinary Stereotactic Radiosurgery System (Gamma Knife, LINAC, CyberKnife) Market Trends Analysis Report 2024-2030, Profiles of Elekta, Accuracy, Varian Medical Systems, ALCEN, and Xstrahl
December 05, 2024 09:27 ET
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Stereotactic Radiosurgery System Market Size, Share and Trends Analysis Report by Product (Gamma Knife, LINAC, CyberKnife), End-use...
Proton Therapy Market Report Global Forecast and Company Analysis 2025-2033, Profiles of Key Players - IBA, Varian Medical System, Hitachi, Mevion Medical Systems, and Mitsubishi Electric
December 05, 2024 05:24 ET
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Proton Therapy Market Report Global Forecast by Indication, Set-up Type, Country and Company Analysis 2025-2033" report has been added to ...
United States Proton Therapy Market Forecasts Report 2025-2033: California, Expanding Insurance Coverage, and Increasing Cancer Incidences Fueling Growth
November 28, 2024 05:55 ET
|
Research and Markets
Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The "United States Proton Therapy Market Report Forecast by Indication. States and Company Analysis 2025-2033" report has been added to ...
Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
November 26, 2024 09:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Asia-Pacific Radiation Oncology Market Analysis Report 2025-2030 - External Beam Radiation Therapy (EBRT) Dominated the Market with a Revenue Share of 35.9% in 2024
November 26, 2024 05:18 ET
|
Research and Markets
Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation...
Saudi Arabia Radiotherapy Markets, Competition, Forecast & Opportunities, 2029, Profiles of Key Players - Gulf Medical, Siemens Industrial, Almana Group of Hospitals, and Varian Medical
November 21, 2024 10:57 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia Radiotherapy Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Shuttle Pharma Provides Third Quarter 2024 Corporate Update
November 13, 2024 17:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
October 29, 2024 09:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
October 28, 2024 16:05 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...